Table 4.
In patients subgrouped by different treatment regimens, no differences in lipid metabolism parameters were demonstrated, even under zinc monotherapy.
| n | Limits of normal | DPA | Trientine | Zinc | Combination | p-value | |
| ALT | 249 | f: -35 U/l m: -50 U/l |
36 (8-3743) |
30 (10-398) |
34.5 (14-162) |
34 (12-100) |
0.133 |
| AST | 250 | f: -35 U/l m: -50 U/l |
28 (11-2106) |
27 (12-167) |
25 (10-110) |
24 (12-79) |
0.775 |
| Bilirubin | 239 | < 1.0 mg/dl | 0.7 (0,3-23) |
0.6 (0.2-4.5) |
0.6 (0.2-10) |
0.8 (0.3-1.8) |
0.306 |
| Albumin | 231 | 30-50 g/l |
44.2 (28-54) |
43 (21-55) |
46 (24-73) |
44.4 (30-56) |
0.033 |
| TG | 247 | < 150 mg/dl | 106 (24-888) |
97 (29-287) |
94 (12-438) |
87 (44-178) |
0.505 |
| Cholesterol | 248 | < 200 mg/dl | 179 (90-288) |
185.5 (107-365) |
187 (122-340) |
172 (137-259) |
0.780 |
| HDL | 124 | f: >50 mg/dl m: >40 mg/dl | 56 (27-103) |
59.5 (39-113) |
54 (39-100) |
48.5 (32-90) |
0.467 |
| LDL | 115 | < 160 mg/dl | 102.5 (43-204) |
98 (52-218) |
113 (51-229) |
94.5 (64-151) |
0.324 |
| BMI | 166 | 18.5-25 kg/m² | 23.7 (18.1-33.7) |
22.5 (14.2-41.1) |
21.9 (15.1-34.1) |
25.2 (18.5-29) |
0.060 |